The Society for Melanoma Research (SMR) Annual Congress is underway in The Netherlands. As part of the SMR Congress, a Pathology Symposium has been held where MIA’s Rob Rawson and Mike Michael Taylor from @UCSF have presented on the International Neoadjuvant Melanoma Consortium

Honoured to present the 64th Lambie Dew Oration @Sydney_Uni ‘Courageous Medicine: From Evidence Users to Evidence Creators’. Thought provoking questions from medical students. I feel confident about the future of our medical workforce - people with compassion, reflection and

Its time to have another community Fan Art event where you make the art, and the community votes their favorite! The top 5 art pieces will be receiving the rewards! RULES: - Anything Hero Siege related - No NSFW - No AI (we will filter these out) - Post progress pictures, at

Great to present at Tenmile’s FocalPoint 2025, a symposium during the #AusBiotech conference in Melbourne - all about ideas to improve #health and making them come alive. For me, it was about curing cancer by focusing on the ‘third space’ - those still dying of #melanoma for whom

Please join me and other @MelanomaAus multidisciplinary experts at our specialist hybrid #symposium on Neoadjuvant Treatment, so we can ensure the recent PBS listings for #neoadjuvant regimens for Stage III melanoma translate into practice and ultimately better patient outcomes.

Melanoma Institute Australia Medical Director, Prof Georgina Long AO, was special guest this week on the Washington Post Live’s Chasing Cancer series, which explores the latest scientific advances driving the next wave of cancer breakthroughs. Prof Long explained the importance

Proud to lead this clinical trial MORPHEUS, comparing different neoadjuvant (pre-surgery) #immunotherapy combinations in stage III #melanoma. Shows how the neoadjuvant platform can deliver comparative clinical and translational data efficiently. anti-PD1+LAG3 and

Prof Georgina Long AO, our MIA Medical Director, had the honour of delivering the 2025 Derrick Mackerras Memorial Lecture at QIMR Berghofer yesterday. Prof Long’s Keynote Address focused on “Melanoma as our Blueprint: Weaving Research into the DNA of Clinical Care”. In the words

I was so honoured and excited to speak to emerging leaders from industries across Australia as part of the American Chamber of Commerce Academy Leadership Program. I spoke about my leadership evolution, my five pillars of leadership growth, as well as my 'third space' leadership

PhD Opportunity. Join our world-leading team at Melanoma Institute Australia & @Sydney_Uni to investigate why liver metastases reduce response to life-saving #immunotherapy in #melanoma & develop new strategies to overcome it. What you’ll do: • Analyse patient immune profiles &

I am so proud of leading the #Neoadjuvant NADINA phase 3 clinical trial (with Dutch colleague Prof Blank from @NKI_nl) and with the support of my amazing colleagues at @MelanomaAus. Today, this #immunotherapy regimen (ipilimumab+nivolumab) is listed on PBS for ALL AUSSIES with

I’m honoured to be recognised as a Fellow of the American Society of Clinical Oncology (#FASCO). The American Society of Clinical Oncology (@ASCO) is the world’s leading professional organisation for oncologists, with a mission to conquer cancer through research, education, and

INNOVATE conference Naples - I love this think tank meeting! 2nd yr colleague Paolo Ascierto has hosted small but lively group of clinician researchers, clinical trialists and drug developers discuss an ALL #CANCER #NEOADJUVANT #immunotherapy approach.  It is one of my favourite

This year, I was proud to be invited to write the foreword for the #JournalOfScienceExtensionResearch. This journal is an incredible initiative of the NSW Department of Education which showcases and celebrates the amazing work of science extension high school students. It

The neoadjuvant (pre-surgery) use of combination immunotherapy as frontline treatment for high risk Stage III melanoma has been approved by the Pharmaceutical Benefits Advisory Committee (#PBAC) and will soon be listed on the #PBS and subsidised for all Australian patients.   The

The inaugural NSW Cancer Summit is being hosted by Cancer Institute NSW on 13 & 14 August. As Co-Chair of the Breakthrough in Oncology stream, I look forward to discussions around new advances in cancer diagnosis and treatment. Find out more > https://t.co/5RVdJOW12H

It was an honour to deliver the Opening Keynote Address at the Asia-Pacific Vaccine and Immunotherapy Congress (APVIC) in Brisbane this week. I spoke about Therapeutic Cancer Vaccine development and Immunotherapies - Melanoma is the ‘paradigm shifter’ in cancer drug development.

I just had the exciting opportunity to speak at the @RACSurgeons conference! My colleagues from @MelanomaAus, Alex van Akkooi and David Coker, hosted the session where I shared groundbreaking work on #neoadjuvant #immunotherapy – giving cancer drugs before surgery, which is